Article
Identifying prognostic gene panels in acute myeloid leukemia.
Expert review of hematology - 1 Apr 2023
Sanchez-Garcia Joaquin, Serrano Josefina, Prados de La Torre Esther, Serrano-López Juana, Aparicio-Perez Clara, Barragán E, Montesinos Pau
Abstract excerpt
INTRODUCTION: Acute myeloid leukemia (AML) is a heterogeneous disease currently including 12 entities defined by genetic findings with remarkable differences in prognosis and targeted therapies availability. Therefore, identification of genetic abnormalities by efficient techniques has become a necessary tool in routine clinical practice for AML patients. AREAS COVERED: In the present review, we will focus on our...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
